PFIZER INC.
đēđ¸United States
- Country
- đēđ¸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation
- First Posted Date
- 2005-10-26
- Last Posted Date
- 2018-12-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1372
- Registration Number
- NCT00244426
- Locations
- đŽđš
Pfizer Investigational Site, Viterbo, Italy
Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer
Phase 2
Completed
- Conditions
- Breast Neoplasms
- Interventions
- Drug: SU011248/Trastuzumab
- First Posted Date
- 2005-10-24
- Last Posted Date
- 2011-07-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 60
- Registration Number
- NCT00243503
- Locations
- đĒđ¸
Pfizer Investigational Site, Valencia, Spain
Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women
Phase 3
Completed
- Conditions
- Endometrial HyperplasiaOsteoporosis
- Interventions
- Other: PlaceboDrug: Bazedoxifene/Conjugated EstrogenDrug: CE 0.45 mg/MPA 1.5mg
- First Posted Date
- 2005-10-20
- Last Posted Date
- 2013-12-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1083
- Registration Number
- NCT00242710
- Locations
- đēđ¸
Pfizer Investigational Site, Pittsburgh, Pennsylvania, United States
Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients
Phase 3
Terminated
- Conditions
- Gram-Positive Bacterial Infections
- First Posted Date
- 2005-10-18
- Last Posted Date
- 2012-05-25
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00240747
- Locations
- đēđ¸
Children's Hospital, Cincinnati, Ohio, United States
đēđ¸Children's Hospital of Orange County, Orange, California, United States
đēđ¸Duke University Medical Center, Durham, North Carolina, United States
Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration
- First Posted Date
- 2005-10-17
- Last Posted Date
- 2011-05-12
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 61
- Registration Number
- NCT00239928
- Locations
- đ¯đĩ
Pfizer Investigational Site, Kyoto, Japan
A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To
Phase 2
Completed
- Conditions
- Sinusitis
- First Posted Date
- 2005-10-04
- Last Posted Date
- 2011-04-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 72
- Registration Number
- NCT00232154
- Locations
- đēđ¸
Pfizer Investigational Site, Philadelphia, Pennsylvania, United States
Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.
Completed
- Conditions
- Invasive Pneumococcal Disease
- Interventions
- Drug: Pneumococcal 7-valent conjugate vaccine Prevnar
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2012-11-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 408
- Registration Number
- NCT00227188
- Locations
- đĒđ¸
Pfizer Investigational Site, Bilbao, Spain
Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis
Completed
- Conditions
- Plaque Psoriasis
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2012-03-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 753
- Registration Number
- NCT00227240
- Locations
- đŠđĒ
Pfizer Investigational Site, Munich, Germany
An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2015-03-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 78
- Registration Number
- NCT00226811
- Locations
- đ¨đŗ
Pfizer Investigational Site, Taipei, Taiwan
Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors
- First Posted Date
- 2005-09-23
- Last Posted Date
- 2018-12-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 121
- Registration Number
- NCT00225121
- Locations
- đēđ¸
Massachusetts General Hospital, Boston, Massachusetts, United States
đēđ¸Dana Farber Cancer Institute, Boston, Massachusetts, United States
đēđ¸Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
Š Copyright 2025. All Rights Reserved by MedPath